Hepatitis B
📧 Sign up to get email alerts when something new happens for Hepatitis B.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-11-21Clinical Trial Update: Safety Study of HBV DNA Vaccine to Treat Patients With Chronic Hepatitis B Infection [Phase 1]
Phase 1 safety study of an HBV DNA vaccine for chronic hepatitis B has completed.
-
CLINICAL_TRIALS trial_result · 2008-10-24Clinical Trial Update: Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B Patients [Phase 2]
This ClinicalTrials.gov entry reports results from a Phase 2 study evaluating different regimens of pegylated interferon in combination with…
-
CLINICAL_TRIALS trial_result · 2008-10-16Clinical Trial Update: Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV) [Phase 3]
Phase 3 study comparing lamivudine plus interferon versus lamivudine for HBeAg-positive chronic hepatitis B has completed.
-
CLINICAL_TRIALS trial_result · 2008-10-01Clinical Trial Update: Safety of and Immune Response to a Hepatitis B Virus Vaccine Given With a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected People [Phase 1, Phase 2]
This completed Phase 1/2 trial evaluated the safety and immune response of a Hepatitis B vaccine given with a CpG7909 ODN booster in adults …
-
CLINICAL_TRIALS trial_result · 2008-09-05Clinical Trial Update: Laboratory Profile of Hepatitis B and C in Users of a Reference Service
A completed clinical trial update describing laboratory findings for Hepatitis B and Hepatitis C among users of a reference laboratory servi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-08-28Clinical Trial Update: A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Responded to Previous Hepatitis B Vaccination But Lost Antibody. [Phase 3]
Phase 3 trial comparing Henogen's adjuvanted Hepatitis B vaccine to Aventis Pasteur MSD's Hepatitis B vaccine in pre-dialysis and dialysis p…
-
CLINICAL_TRIALS trial_result · 2008-08-28Clinical Trial Update: Compare the Immune Response & Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine vs Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis & Dialysis Patients Who Did Not Respond to Previous Hepatitis B Vaccination [Phase 3]
Phase 3 trial comparing immune response and safety of Henogen's adjuvanted Hepatitis B vaccine with Aventis Pasteur MSD's Hepatitis B vaccin…
-
CLINICAL_TRIALS trial_result · 2008-08-28Clinical Trial Update: A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to GSK Biologicals Adjuvanted Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Have Not Been Exposed to Hepatitis B. [Phase 3]
A completed Phase 3 trial comparing Henogen's adjuvanted hepatitis B vaccine with GSK's Engerix-B adjuvanted vaccine in pre-dialysis and dia…
-
CLINICAL_TRIALS trial_result · 2008-08-25Clinical Trial Update: Consistency Study of Three Lots of Henogen's Adjuvanted Hepatitis B Vaccine When Given in 0, 1 Month Schedule [Phase 3]
Phase 3 consistency study evaluating three manufacturing lots of Henogen's adjuvanted hepatitis B vaccine given on a 0 and 1 month schedule;…
-
CLINICAL_TRIALS trial_result · 2008-06-30Clinical Trial Update: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Lamivudine Resistant HBeAg-Negative Chronic Hepatitis B. [Phase 4]
A Phase 4 study of PEGASYS (pegylated interferon alfa-2a) in lamivudine-resistant HBeAg-negative chronic hepatitis B was terminated.
-
CLINICAL_TRIALS trial_result · 2008-06-20Clinical Trial Update: Seroprevalence of Hepatitis B Infection and Effect of Booster Response Amongst Taiwanese Young Adults
This clinical trial update reports on the seroprevalence of Hepatitis B infection among Taiwanese young adults and the immune response to a …
-
CLINICAL_TRIALS trial_result · 2008-06-17Clinical Trial Update: Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 19-40 y [Phase 2]
A Phase 2 trial update comparing immunogenicity and safety of different formulations of an HBV-MPL vaccine with Engerix-B in adults aged 19-…
-
CLINICAL_TRIALS trial_result · 2008-06-17Clinical Trial Update: Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 18-40 y [Phase 2]
This Phase 2 study assesses immunogenicity and safety of various HBV-MPL vaccine formulations compared with Engerix-B in adults aged 18-40; …
-
CLINICAL_TRIALS trial_result · 2008-06-17Clinical Trial Update: Evaluation of Immunogenicity, Reactogenicity and Safety of HBV-MPL Vaccine vs Engerix™-B, in Haemodialysis Patients [Phase 1]
Phase 1 trial comparing an HBV-MPL adjuvanted hepatitis B vaccine to Engerix-B in haemodialysis patients assessed immunogenicity, reactogeni…
-
CLINICAL_TRIALS trial_result · 2008-06-16Clinical Trial Update: Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine (2 Doses), and of Engerix™-B (3 Doses) in Healthy Adults [Phase 2]
Phase 2 trial update evaluating immunogenicity and safety of GSK's HBV-MPL vaccine given in 2-dose schedule versus Engerix-B given in a 3-do…
-
CLINICAL_TRIALS trial_result · 2008-06-16Clinical Trial Update: Safety and Immunogenicity of GSK Bio's Candidate HBV-MPL Vaccines Compared to Engerix™-B, in Healthy Adolescents [Phase 2]
Phase 2 clinical trial comparing GSK's HBV-MPL vaccine candidate to Engerix-B in healthy adolescents to evaluate safety and immunogenicity; …
-
CLINICAL_TRIALS trial_result · 2008-06-16Clinical Trial Update: Comparison of Safety, Immuno- and Reactogenicity of MPL-Adjuvanted Recombinant Hepatitis B Vaccine to That of Engerix™-B [Phase 3]
This Phase 3 trial compares the safety, immunogenicity, and reactogenicity of an MPL-adjuvanted recombinant hepatitis B vaccine to Engerix-B…
-
CLINICAL_TRIALS trial_result · 2008-06-16Clinical Trial Update: Immunogenicity and Reactogenicity of MPL Adjuvanted Recombinant Hepatitis B- Vaccine and Engerix™-B in Adult Non-Responders [Phase 3]
Phase 3 clinical trial evaluating the immunogenicity and reactogenicity of an MPL-adjuvanted recombinant Hepatitis B vaccine versus Engerix-…
-
CLINICAL_TRIALS trial_result · 2008-06-16Clinical Trial Update: Safety, Immunogenicity and Reactogenicity of Recombinant Hepatitis B Vaccine (Adjuvanted & New Formulation) and Engerix™-B [Phase 3]
Phase 3 study evaluating safety, immunogenicity and reactogenicity of an adjuvanted recombinant Hepatitis B vaccine with a new formulation a…
-
CLINICAL_TRIALS trial_result · 2008-06-16Clinical Trial Update: Evaluation of Immunogenicity and Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine [Phase 3]
Phase 3 trial update evaluating immunogenicity and reactogenicity of various formulations of recombinant hepatitis B vaccine conducted by Gl…
-
CLINICAL_TRIALS trial_result · 2008-06-13Clinical Trial Update: Immunogenicity & Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine With Different Adjuvants [Phase 2]
Phase 2 trial evaluating immunogenicity and reactogenicity of multiple formulations of recombinant hepatitis B vaccine with different adjuva…
-
CLINICAL_TRIALS trial_result · 2008-06-13Clinical Trial Update: Comparison of Immuno, Reacto and Safety of Recombinant Hepatitis B Vaccine With or Without MPL in Healthy Older Adults [Phase 3]
Phase 3 trial comparing the immunogenicity and safety of recombinant hepatitis B vaccine with MPL adjuvant versus without MPL in healthy old…
-
CLINICAL_TRIALS trial_result · 2008-06-13Clinical Trial Update: Immunogenicity & Reactogenicity of HBV-MPL Vaccine and Engerix™-B in Healthy Adults Following 2 Different Schedules [Phase 2]
Phase 2 clinical trial comparing the immunogenicity and reactogenicity of HBV-MPL vaccine and Engerix-B across two dosing schedules in healt…
-
CLINICAL_TRIALS trial_result · 2008-06-13Clinical Trial Update: Study Comparing Immunogenicity, Reactogenicity and Safety of GSK Bios' HBV-MPL Vaccine With That of Engerix™-B in Adults [Phase 3]
A Phase 3 study comparing the immunogenicity, reactogenicity, and safety of GSK's HBV-MPL vaccine versus Engerix-B in adults with Hepatitis …
-
CLINICAL_TRIALS trial_result · 2008-06-13Clinical Trial Update: Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Adults (15-40 Yrs). [Phase 3]
Phase 3 trial update reporting immunogenicity and safety data for GSK's HBV-MPL vaccine and Engerix-B in healthy adults aged 15-40; the stud…